TRIM8

tripartite motif containing 8, the group of Tripartite motif family|Ring finger proteins

Basic information

Region (hg38): 10:102642503-102662789

Previous symbols: [ "RNF27" ]

Links

ENSG00000171206NCBI:81603OMIM:606125HGNC:15579Uniprot:Q9BZR9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • genetic developmental and epileptic encephalopathy (Supportive), mode of inheritance: AD
  • focal segmental glomerulosclerosis and neurodevelopmental syndrome (Strong), mode of inheritance: AD
  • focal segmental glomerulosclerosis and neurodevelopmental syndrome (Definitive), mode of inheritance: AD
  • focal segmental glomerulosclerosis and neurodevelopmental syndrome (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Focal segmental glomerulosclerosis and neurodevelopmental syndromeADRenalAmong other features, the condition can include renal disease, and awareness may allow early diagnosis and managementCraniofacial; Musculoskeletal; Renal23934111; 27346735; 30244534; 32193649; 32531461; 33508234
Renal transplant has been described

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TRIM8 gene.

  • not_provided (362 variants)
  • Inborn_genetic_diseases (38 variants)
  • Focal_segmental_glomerulosclerosis_and_neurodevelopmental_syndrome (23 variants)
  • TRIM8-related_disorder (13 variants)
  • Seizure (9 variants)
  • Focal_segmental_glomerulosclerosis (8 variants)
  • Neurodevelopmental_delay (8 variants)
  • not_specified (3 variants)
  • TRIM8-related_epileptic_encephalopathy (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRIM8 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000030912.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
120
clinvar
7
clinvar
128
missense
149
clinvar
52
clinvar
5
clinvar
206
nonsense
9
clinvar
6
clinvar
5
clinvar
20
start loss
1
1
frameshift
1
clinvar
4
clinvar
5
clinvar
10
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total 10 10 162 172 12
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TRIM8protein_codingprotein_codingENST00000302424 613912
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9940.00562125742061257480.0000239
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.741983400.5820.00002013574
Missense in Polyphen3895.3990.398331116
Synonymous1.421391620.8580.00001091082
Loss of Function4.18224.20.08260.00000113259

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001240.000123
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004620.0000462
European (Non-Finnish)0.00002880.0000264
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: E3 ubiquitin-protein ligase which plays different roles in immune pathways. Participates in the activation of interferon- gamma signaling by promoting proteasomal degradation of the repressor SOCS1 (PubMed:12163497). Plays a positive role in the TNFalpha and IL-1beta signaling pathways. Mechanistically, induces the 'lys-63' polyubiquitination of MAP3K7/TAK1 component leading to the activation of NF-kappa-B (PubMed:22084099, PubMed:23152791). Modulates also STAT3 activity through negative regulation of PIAS3, either by degradation of PIAS3 through the ubiquitin-proteasome pathway or exclusion of PIAS3 from the nucleus (PubMed:20516148). {ECO:0000269|PubMed:12163497, ECO:0000269|PubMed:20516148, ECO:0000269|PubMed:22084099, ECO:0000269|PubMed:23152791}.;
Pathway
Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling (Consensus)

Recessive Scores

pRec
0.125

Intolerance Scores

loftool
rvis_EVS
-0.56
rvis_percentile_EVS
19.31

Haploinsufficiency Scores

pHI
0.467
hipred
Y
hipred_score
0.783
ghis
0.674

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.776

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Trim8
Phenotype

Gene ontology

Biological process
positive regulation of autophagy;protein ubiquitination;stem cell population maintenance;negative regulation of viral transcription;positive regulation of I-kappaB kinase/NF-kappaB signaling;innate immune response;negative regulation of viral entry into host cell;positive regulation of DNA-binding transcription factor activity;positive regulation of NF-kappaB transcription factor activity;interferon-gamma-mediated signaling pathway;positive regulation of protein localization to nucleus;negative regulation of viral release from host cell
Cellular component
cytosol;PML body
Molecular function
protein binding;zinc ion binding;transferase activity;identical protein binding;protein homodimerization activity